DFM:NIH Statistics

Total Valuation

DFM:NIH has a market cap or net worth of AED 458.09 million. The enterprise value is 537.62 million.

Market Cap	458.09M
Enterprise Value	537.62M

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	Jul 9, 2024

Share Statistics

Current Share Class	245.64M
Shares Outstanding	n/a
Shares Change (YoY)	-0.47%
Shares Change (QoQ)	-1.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	154.24M

Valuation Ratios

The trailing PE ratio is 20.92.

PE Ratio	20.92
Forward PE	n/a
PS Ratio	4.60
PB Ratio	0.79
P/TBV Ratio	0.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.16, with an EV/FCF ratio of -36.26.

EV / Earnings	24.55
EV / Sales	5.34
EV / EBITDA	11.16
EV / EBIT	11.71
EV / FCF	-36.26

Financial Position

The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.05.

Current Ratio	5.06
Quick Ratio	4.67
Debt / Equity	0.05
Debt / EBITDA	0.64
Debt / FCF	-2.06
Interest Coverage	19.07

Financial Efficiency

Return on equity (ROE) is 4.36% and return on invested capital (ROIC) is 4.72%.

Return on Equity (ROE)	4.36%
Return on Assets (ROA)	4.32%
Return on Invested Capital (ROIC)	4.72%
Return on Capital Employed (ROCE)	7.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.15
Inventory Turnover	3.73

Taxes

In the past 12 months, DFM:NIH has paid 98,805 in taxes.

Income Tax	98,805
Effective Tax Rate	0.40%

Stock Price Statistics

The stock price has increased by +24.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+24.08%
50-Day Moving Average	1.82
200-Day Moving Average	2.43
Relative Strength Index (RSI)	55.93
Average Volume (20 Days)	6,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DFM:NIH had revenue of AED 99.53 million and earned 21.90 million in profits. Earnings per share was 0.09.

Revenue	99.53M
Gross Profit	65.97M
Operating Income	45.36M
Pretax Income	24.89M
Net Income	21.90M
EBITDA	47.58M
EBIT	45.36M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 57.80 million in cash and 30.55 million in debt, giving a net cash position of 27.24 million.

Cash & Cash Equivalents	57.80M
Total Debt	30.55M
Net Cash	27.24M
Net Cash Per Share	n/a
Equity (Book Value)	577.07M
Book Value Per Share	1.92
Working Capital	101.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.77 million and capital expenditures -1.06 million, giving a free cash flow of -14.83 million.

Operating Cash Flow	-13.77M
Capital Expenditures	-1.06M
Free Cash Flow	-14.83M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 66.28%, with operating and profit margins of 45.58% and 22.00%.

Gross Margin	66.28%
Operating Margin	45.58%
Pretax Margin	25.01%
Profit Margin	22.00%
EBITDA Margin	47.80%
EBIT Margin	45.58%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 3.67%.

Dividend Per Share	0.07
Dividend Yield	3.67%
Dividend Growth (YoY)	20.30%
Years of Dividend Growth	3
Payout Ratio	71.79%
Buyback Yield	0.47%
Shareholder Yield	4.14%
Earnings Yield	4.78%
FCF Yield	-3.24%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 24, 2025. It was a forward split with a ratio of 1.06.

Last Split Date	Jun 24, 2025
Split Type	Forward
Split Ratio	1.06

Scores

DFM:NIH has an Altman Z-Score of 4.1 and a Piotroski F-Score of 6.

Altman Z-Score	4.1
Piotroski F-Score	6